Literature DB >> 21474585

Combating antimicrobial resistance: policy recommendations to save lives.

Brad Spellberg, Martin Blaser, Robert J Guidos, Helen W Boucher, John S Bradley, Barry I Eisenstein, Dale Gerding, Ruth Lynfield, L Barth Reller, John Rex, David Schwartz, Edward Septimus, Fred C Tenover, David N Gilbert.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21474585      PMCID： PMC3738230          DOI： 10.1093/cid/cir153

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  100 in total

1.  The United States Food and Drug Administration and noninferiority margins in clinical trials of antimicrobial agents.

Authors:  John H Powers; David B Ross; Erica Brittain; Renata Albrecht; Mark J Goldberger
Journal:  Clin Infect Dis       Date:  2002-03-15       Impact factor: 9.079

Review 2.  Why is big Pharma getting out of antibacterial drug discovery?

Authors:  Steven J Projan
Journal:  Curr Opin Microbiol       Date:  2003-10       Impact factor: 7.934

Review 3.  The abandonment of antibacterials: why and wherefore?

Authors:  David M Shlaes
Journal:  Curr Opin Pharmacol       Date:  2003-10       Impact factor: 5.547

4.  The FDA and the case of Ketek.

Authors:  David B Ross
Journal:  N Engl J Med       Date:  2007-04-19       Impact factor: 91.245

5.  Increasing resistance of acinetobacter species to imipenem in United States hospitals, 1999-2006.

Authors:  Marc S Hoffmann; Michael R Eber; Ramanan Laxminarayan
Journal:  Infect Control Hosp Epidemiol       Date:  2010-02       Impact factor: 3.254

6.  Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes.

Authors:  A C White; R L Atmar; J Wilson; T R Cate; C E Stager; S B Greenberg
Journal:  Clin Infect Dis       Date:  1997-08       Impact factor: 9.079

7.  Diagnosing streptococcal sore throat in adults: randomized controlled trial of in-office aids.

Authors:  Graham Worrall; James Hutchinson; Gregory Sherman; Joseph Griffiths
Journal:  Can Fam Physician       Date:  2007-04       Impact factor: 3.275

8.  Attributable hospital cost and length of stay associated with health care-associated infections caused by antibiotic-resistant gram-negative bacteria.

Authors:  Patrick D Mauldin; Cassandra D Salgado; Ida Solhøj Hansen; Darshana T Durup; John A Bosso
Journal:  Antimicrob Agents Chemother       Date:  2009-10-19       Impact factor: 5.191

9.  Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship.

Authors:  Rebecca R Roberts; Bala Hota; Ibrar Ahmad; R Douglas Scott; Susan D Foster; Fauzia Abbasi; Shari Schabowski; Linda M Kampe; Ginevra G Ciavarella; Mark Supino; Jeremy Naples; Ralph Cordell; Stuart B Levy; Robert A Weinstein
Journal:  Clin Infect Dis       Date:  2009-10-15       Impact factor: 9.079

Review 10.  Antimicrobial agents for complicated skin and skin-structure infections: justification of noninferiority margins in the absence of placebo-controlled trials.

Authors:  Brad Spellberg; George H Talbot; Helen W Boucher; John S Bradley; David Gilbert; W Michael Scheld; John Edwards; John G Bartlett
Journal:  Clin Infect Dis       Date:  2009-08-01       Impact factor: 9.079
View more
  232 in total

1.  The critical impact of time discounting on economic incentives to overcome the antibiotic market failure.

Authors:  Brad Spellberg; Priya Sharma; John H Rex
Journal:  Nat Rev Drug Discov       Date:  2012-02-01       Impact factor: 84.694

2.  Unmet medical need in infectious diseases.

Authors:  Adam L Hersh; Jason G Newland; Susan E Beekmann; Philip M Polgreen; David N Gilbert
Journal:  Clin Infect Dis       Date:  2012-04-02       Impact factor: 9.079

3.  Biophysical Studies of Bacterial Topoisomerases Substantiate Their Binding Modes to an Inhibitor.

Authors:  CongBao Kang; Yan Li; Joseph Cherian; Boping Liu; Hui Qi Ng; Michelle Yueqi Lee; Nur Huda Binte Ahmad; Zhi Ying Poh; Yun Xuan Wong; Qiwei Huang; Ying Lei Wong; Alvin W Hung; Jeffrey Hill; Thomas H Keller
Journal:  Biophys J       Date:  2015-11-03       Impact factor: 4.033

4.  RNase I Modulates Escherichia coli Motility, Metabolism, and Resistance.

Authors:  Yashasvika Duggal; Benjamin M Fontaine; Deanna M Dailey; Gang Ning; Emily E Weinert
Journal:  ACS Chem Biol       Date:  2020-07-02       Impact factor: 5.100

5.  Antibiotic resistance as collateral damage: the tragedy of the commons in a two-disease setting.

Authors:  Daozhou Gao; Thomas M Lietman; Travis C Porco
Journal:  Math Biosci       Date:  2015-02-26       Impact factor: 2.144

Review 6.  Therapies for multidrug resistant and extensively drug-resistant non-fermenting gram-negative bacteria causing nosocomial infections: a perilous journey toward 'molecularly targeted' therapy.

Authors:  Nadim G El Chakhtoura; Elie Saade; Alina Iovleva; Mohamad Yasmin; Brigid Wilson; Federico Perez; Robert A Bonomo
Journal:  Expert Rev Anti Infect Ther       Date:  2018-01-16       Impact factor: 5.091

7.  Antimicrobial stewardship - can we afford to do without it?

Authors:  Anna Aryee; Nicholas Price
Journal:  Br J Clin Pharmacol       Date:  2015-02       Impact factor: 4.335

8.  Resistance suppression by high-intensity, short-duration aminoglycoside exposure against hypermutable and non-hypermutable Pseudomonas aeruginosa.

Authors:  Vanessa E Rees; Jürgen B Bulitta; Antonio Oliver; Brian T Tsuji; Craig R Rayner; Roger L Nation; Cornelia B Landersdorfer
Journal:  J Antimicrob Chemother       Date:  2016-08-11       Impact factor: 5.790

Review 9.  Antimicrobial AApeptides.

Authors:  Peng Sang; Yan Shi; Peng Teng; Annie Cao; Hai Xu; Qi Li; Jianfeng Cai
Journal:  Curr Top Med Chem       Date:  2017       Impact factor: 3.295

10.  Population pharmacokinetics of meropenem in elderly patients: dosing simulations based on renal function.

Authors:  Muhammad Usman; Otto R Frey; Georg Hempel
Journal:  Eur J Clin Pharmacol       Date:  2016-12-13       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.